Saritas Turgay, Reinartz Sebastian Daniel, Nadal Jennifer, Schmoee Jonas, Schmid Matthias, Marwan Mohamed, Achenbach Stephan, Störk Stefan, Wanner Christoph, Eckardt Kai-Uwe, Floege Jürgen, Peter Schneider Markus, Schlieper Georg
Department of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, Germany.
Clin Kidney J. 2019 Apr 8;13(4):571-579. doi: 10.1093/ckj/sfz030. eCollection 2020 Aug.
Epicardial adipose tissue (EAT) exerts cardiopathogenic effects, but the independent association between EAT and cardiovascular (CV) calcification in patients with chronic kidney disease (CKD) remains controversial. We therefore assessed the association between EAT, CV risk factors and CV calcifications.
257 patients with CKD Stage 3 and/or overt proteinuria underwent quantification of EAT, coronary artery calcification and aortic valve calcification by computed tomography. Framingham and American College of Cardiology and American Heart Association (ACC-AHA) 10-year CV event risk scores were calculated for each patient.
Using multivariable regression analysis, higher EAT was significantly associated with the majority of investigated risk factors {higher age: odds ratio [OR] 1.05/year [95% confidence interval (CI) 1.02-1.08]; male sex: OR 4.03 [95% CI 2.22-7.31]; higher BMI: OR 1.28/kg/m [95% CI 1.20-1.37]; former smoking: OR 1.84 [95% CI 1.07-3.17]; lower high-density lipoprotein cholesterol: OR 0.98/mg/dL [95% CI 0.96-1.00] and lower estimated glomerular filtration rate: OR 0.98/mL/min/1.73 m [95% CI 0.97-0.99]; all P < 0.05} and was not associated with diabetes mellitus, hypertensive nephropathy, total cholesterol and albuminuria. EAT was positively associated with higher ACC-AHA and Framingham risk scores. EAT correlated with coronary artery calcification and aortic valve calcification [Spearman ρ = 0.388 (95% CI 0.287-0.532) and = 0.409 (95% CI 0.310-0.556), respectively], but these correlations were dependent on CV risk factors.
The increase of EAT can be explained by individual CV risk factors and kidney function and correlates with 10-year risk for CV event scores, suggesting that EAT is a modifiable risk factor in patients with CKD. Although EAT correlates with CV calcifications, these relations depend on CV risk factors.
心外膜脂肪组织(EAT)具有致心脏病作用,但在慢性肾脏病(CKD)患者中,EAT与心血管(CV)钙化之间的独立关联仍存在争议。因此,我们评估了EAT、CV危险因素与CV钙化之间的关联。
257例CKD 3期和/或显性蛋白尿患者接受了计算机断层扫描,对EAT、冠状动脉钙化和主动脉瓣钙化进行定量分析。为每位患者计算弗雷明汉及美国心脏病学会和美国心脏协会(ACC - AHA)的10年CV事件风险评分。
采用多变量回归分析,较高的EAT与大多数研究的危险因素显著相关{年龄较大:比值比[OR]为每年1.05[95%置信区间(CI)1.02 - 1.08];男性:OR为4.03[95%CI 2.22 - 7.31];较高的体重指数:OR为1.28/(kg/m²)[95%CI 1.20 - 1.37];既往吸烟:OR为1.84[95%CI 1.07 - 3.17];较低的高密度脂蛋白胆固醇:OR为0.98/(mg/dL)[95%CI 0.96 - 1.00]以及较低的估计肾小球滤过率:OR为0.98/(mL/min/1.73m²)[95%CI 0.97 - 0.99];所有P < 0.05},且与糖尿病、高血压肾病、总胆固醇和蛋白尿无关。EAT与较高的ACC - AHA和弗雷明汉风险评分呈正相关。EAT与冠状动脉钙化和主动脉瓣钙化相关[斯皮尔曼ρ分别为0.388(95%CI 0.287 - 0.532)和0.409(95%CI 0.310 - 0.556)],但这些相关性取决于CV危险因素。
EAT的增加可由个体CV危险因素和肾功能来解释,并与10年CV事件风险评分相关,这表明EAT是CKD患者中一个可改变的危险因素。虽然EAT与CV钙化相关,但这些关系取决于CV危险因素。